Not medical advice. Talk to your provider before using any peptide.
Full disclaimerThe only peer-reviewed human BPC-157 clinical trial, published in Alternative Therapies (2021). Dr. Edwin Lee injected 4mg BPC-157 directly into knee joints. Seven out of 12 patients reported pain relief lasting 6+ months from a single injection. The route is intra-articular, not subcutaneous. This is a physician-administered procedure, not a self-injection protocol.
Subjective pain reduction often reported within 24-48 hours: likely analgesic/NO effect rather than structural healing. Many users notice improved sleep quality at the injury site. First-injection anxiety and palpitations peak in this window.
Reduced swelling and tenderness at injury. Gut users report bloating and discomfort improvement. Most side effects (palpitations, nausea) have resolved or become manageable by end of Week 2.
Noticeably improved range of motion. Significant pain reduction with movement. Many users return to light training. Gut protocol users often report near-complete resolution of chronic GI symptoms.
For educational purposes only. Not medical advice. Consult a healthcare provider before starting any peptide protocol.
